#  @TayshaGTx Taysha Gene Therapies Taysha Gene Therapies posts on X about share, $tsha, fda, events the most. They currently have [---] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours. ### Engagements: [--] [#](/creator/twitter::1254996205873971201/interactions)  - [--] Week [--] +986% - [--] Month [--] -58% - [--] Months [-----] +1.60% - [--] Year [-----] -20% ### Mentions: [--] [#](/creator/twitter::1254996205873971201/posts_active)  - [--] Week [--] +50% - [--] Month [--] +200% - [--] Months [--] +146% - [--] Year [--] +65% ### Followers: [---] [#](/creator/twitter::1254996205873971201/followers)  - [--] Week [---] no change - [--] Year [---] +9.20% ### CreatorRank: undefined [#](/creator/twitter::1254996205873971201/influencer_rank)  ### Social Influence **Social category influence** [countries](/list/countries) [finance](/list/finance) **Social topic influence** [share](/topic/share), [$tsha](/topic/$tsha), [fda](/topic/fda), [events](/topic/events), [community](/topic/community), [ceo](/topic/ceo), [protocol](/topic/protocol), [ready](/topic/ready), [break](/topic/break), [director](/topic/director) **Top accounts mentioned or mentioned by** [@rettsyndromes](/creator/undefined) [@rettsyndrome](/creator/undefined) [@rarediseases](/creator/undefined) [@neurogeneinc](/creator/undefined) [@bostonchildrens](/creator/undefined) [@asgctherapys](/creator/undefined) [@officialcantor](/creator/undefined) [@asgctherapy](/creator/undefined) [@ontariorettsas](/creator/undefined) [@tayshagenetherapies](/creator/undefined) [@rsrts](/creator/undefined) [@rallybio](/creator/undefined) [@sofinnovavc](/creator/undefined) [@orbimed](/creator/undefined) [@ajtesler](/creator/undefined) [@magnoliashope](/creator/undefined) [@rarediseaseday](/creator/undefined) [@acadiapharma](/creator/undefined) [@mpssociety](/creator/undefined) [@themightysite](/creator/undefined) **Top assets mentioned** [Taysha Gene Therapies, Inc. (TSHA)](/topic/$tsha) ### Top Social Posts Top posts by engagements in the last [--] hours "July is #FragileXSyndrome Awareness Month. #FXS is the most common single gene cause of autism and cognitive impairment affecting 100K individuals globally. This disease is diagnosed around [--] years old and is characterized in many ways" [X Link](https://x.com/TayshaGTx/status/1411002959199039489) 2021-07-02T16:44Z [---] followers, [--] engagements "Wishing you a Happy New Year from all of us at Taysha Gene Therapies" [X Link](https://x.com/TayshaGTx/status/1609594270150787075) 2023-01-01T16:55Z [---] followers, [---] engagements "Hear from Sarah Davenport CPA our Corporate Controller on what inspires her as a #RareAlly" [X Link](https://x.com/TayshaGTx/status/1613225440650399758) 2023-01-11T17:24Z [---] followers, [---] engagements "#RareDiseaseDay is right around the corner and all month long our team is raising awareness for #raredisease including those that are genetic and affecting children as early as birth. Join us as we #ShowYourStripes and #CareAboutRare" [X Link](https://x.com/TayshaGTx/status/1623376971316051968) 2023-02-08T17:43Z [---] followers, [---] engagements "Worldwide people live with rare disease and the impact goes beyond health itself as its felt in many aspects of a persons life. At #TayshaGeneTherapies we raise awareness of the 7K+ #rarediseases & show support for the millions of people living with a rare disease. #RareAlly" [X Link](https://x.com/TayshaGTx/status/1623746127290851330) 2023-02-09T18:10Z [---] followers, [---] engagements "The FDA is hosting Rare Disease Day a virtual public meeting on February 27th - registration is free and open to the public Learn more at https://bit.ly/FDARareDiseaseDay https://bit.ly/FDARareDiseaseDay" [X Link](https://x.com/TayshaGTx/status/1626015982576623618) 2023-02-16T00:29Z [---] followers, [---] engagements "We asked Dr. Nagendran Tayshas new President and Head of Research & Development what has inspired him in drug development in rare diseases. #RareDiseaseDay #RareAlly" [X Link](https://x.com/TayshaGTx/status/1626319109309825026) 2023-02-16T20:34Z [---] followers, [---] engagements "Chief Corporate Affairs Officer Kim Lee reflects on how collective efforts from the rare disease communities are instrumental in the daily work at Taysha. #RareAlly" [X Link](https://x.com/TayshaGTx/status/1628101497710837770) 2023-02-21T18:37Z [---] followers, [---] engagements "#RareDiseaseDay is an opportunity for us to honor the unique differences & strength of the entire #raredisease community that inspire us daily. No matter where you are in the world today brings us together as a #RareAlly #Taysha" [X Link](https://x.com/TayshaGTx/status/1630695540517117955) 2023-02-28T22:24Z [---] followers, [---] engagements "Today we announced our fourth quarter and full year [----] earnings. Learn more: http://bit.ly/3M2fylt http://bit.ly/3M2fylt" [X Link](https://x.com/TayshaGTx/status/1640807607156854802) 2023-03-28T20:06Z [---] followers, [---] engagements "We are excited to announce new preclinical data for our TSHA-102 #genetherapy program in evaluation for Rett Syndrome will be presented at the #ASGCT23 Annual Meeting on May [--]. Learn more: https://bit.ly/3NlrD66 https://bit.ly/3NlrD66" [X Link](https://x.com/TayshaGTx/status/1651693718808788999) 2023-04-27T21:04Z [---] followers, [---] engagements "Next week we will announce our first quarter [----] earnings and provide a corporate update. For more information visit: https://bit.ly/3I1MNTp https://bit.ly/3I1MNTp" [X Link](https://x.com/TayshaGTx/status/1654100105585217538) 2023-05-04T12:26Z [---] followers, [---] engagements "Today we announced our first quarter [----] earnings. Learn more: https://bit.ly/3LRbrae https://bit.ly/3LRbrae" [X Link](https://x.com/TayshaGTx/status/1656752138335186971) 2023-05-11T20:04Z [---] followers, [---] engagements "This week at #ASGCT23 we present new preclinical data that supports the continued development of our TSHA-102 #genetherapy program in evaluation for Rett Syndrome. Learn more: https://bit.ly/3IpDywc https://bit.ly/3IpDywc" [X Link](https://x.com/TayshaGTx/status/1659534889958424577) 2023-05-19T12:22Z [---] followers, [---] engagements "We are excited to participate in the @Rettsyndromes [----] IRSF Rett Syndrome Scientific Meeting. We look forward to sharing updates on our investigational TSHA-102 program and research on caregiver perspectives of #genetherapy clinical trials during upcoming presentations" [X Link](https://x.com/TayshaGTx/status/1664702458151555093) 2023-06-02T18:36Z [---] followers, [---] engagements "We are excited to announce the first patient has been dosed in the REVEAL Phase 1/2 trial evaluating our investigational AAV9 #genetherapy for #Rettsyndrome. Learn more: https://bit.ly/3MPlk8T https://bit.ly/3MPlk8T" [X Link](https://x.com/TayshaGTx/status/1665698809622540290) 2023-06-05T12:35Z [---] followers, [---] engagements "Looking forward to sharing updates on our investigational programs in evaluation for Rett syndrome and giant axonal neuropathy (GAN) at our upcoming R&D Day. Register here: https://lifesci.events/Taysha Join us on June [--] at 10am ET for a Virtual R&D Day with @TayshaGTx featuring Salman Bhai MD discussing updates for TSHA-120 being investigated in giant axonal neuropathy (GAN) and TSHA-102 being investigated in Rett syndrome. $TSHA Register here: https://t.co/GV3n0WNzpE https://t.co/NnSOkdL00T https://lifesci.events/Taysha Join us on June [--] at 10am ET for a Virtual R&D Day with @TayshaGTx" [X Link](https://x.com/TayshaGTx/status/1666848990002913281) 2023-06-08T16:45Z [---] followers, [---] engagements "Our President and Head of R&D Suku Nagendran M.D. and his wife Ann created the Jerry Mendell Award for Translational Science in partnership with @ASGCTherapy to help the next generation of scientists develop #genetherapies. Congratulations to the [----] recipients. ASGCT is grateful to member Suku Nagendran MD (@TayshaGTX) and his wife Ann for their generous giftfunding the Jerry Mendell award in perpetuity to encourage #genetherapy development. https://t.co/MtJY6ce3AV https://t.co/VLVXgFfDzO ASGCT is grateful to member Suku Nagendran MD (@TayshaGTX) and his wife Ann for their generous" [X Link](https://x.com/TayshaGTx/status/1668654520480432128) 2023-06-13T16:20Z [---] followers, [---] engagements "We look forward to discussing updates on our investigational #genetherapy programs for Rett syndrome and giant axonal neuropathy (GAN) at our virtual R&D Day on June [--]. Learn more about the event and register today: https://bit.ly/3p7eP9E https://bit.ly/3p7eP9E" [X Link](https://x.com/TayshaGTx/status/1669316525696712708) 2023-06-15T12:10Z [---] followers, [---] engagements "Dont forget tune in to our virtual R&D Day today at [--] a.m. ET to hear the latest in the development of our investigational #genetherapies in giant axonal neuropathy (GAN) and Rett syndrome. https://bit.ly/3NPTiM3 https://bit.ly/3NPTiM3" [X Link](https://x.com/TayshaGTx/status/1674027056076603392) 2023-06-28T12:08Z [---] followers, [---] engagements "Were pleased to share the IDMC recommended the continuation of the REVEAL Phase 1/2 trial evaluating TSHA-102 in adults with #RettSyndrome. Learn more: https://bit.ly/458bc2x https://bit.ly/458bc2x" [X Link](https://x.com/TayshaGTx/status/1685988782451945474) 2023-07-31T12:20Z [---] followers, [----] engagements "Today we announced a $150 million private placement financing. We are pleased by the support from new and existing investors and believe we are well positioned to continue to execute across key program milestones. Learn more: https://bit.ly/3DW1pRO https://bit.ly/3DW1pRO" [X Link](https://x.com/TayshaGTx/status/1691092856424034304) 2023-08-14T14:22Z [---] followers, [---] engagements "We announced our second quarter [----] earnings today and provided updates including the initial clinical data from the first adult #Rettsyndrome patient dosed in the REVEAL Phase 1/2 trial. #genetherapy Learn more: https://bit.ly/3KFzWHP https://bit.ly/3KFzWHP" [X Link](https://x.com/TayshaGTx/status/1691114329003917312) 2023-08-14T15:47Z [---] followers, [----] engagements "The U.S. FDA granted Fast Track Designation to TSHA-102 our investigational #genetherapy in clinical evaluation for #Rettsyndrome. Learn more: https://bit.ly/3OM3Dbb https://bit.ly/3OM3Dbb" [X Link](https://x.com/TayshaGTx/status/1694682671744524341) 2023-08-24T12:06Z [---] followers, [---] engagements "We are pleased to announce the second adult patient has been dosed in the REVEAL Phase 1/2 trial evaluating TSHA-102 in #Rettsyndrome. Learn more: #genetherapy https://bit.ly/3rsWkO4 https://bit.ly/3rsWkO4" [X Link](https://x.com/TayshaGTx/status/1706641780165230753) 2023-09-26T12:08Z [---] followers, [---] engagements "This week we joined industry leaders at the [----] Cantor Global Healthcare Conference to discuss company updates and the latest developments shaping the #genetherapy landscape. Learn more about our approach: https://tayshagtx.com/approach/ https://tayshagtx.com/approach/" [X Link](https://x.com/TayshaGTx/status/1707545390390669572) 2023-09-28T23:58Z [---] followers, [---] engagements "October is #RettSyndromeAwarenessMonth and were proud to join the Rett syndrome community in raising awareness of #Rettsyndrome a rare neurodevelopmental disorder caused by mutations in the MECP2 gene. Learn more: https://www.ninds.nih.gov/health-information/disorders/rett-syndrome https://www.ninds.nih.gov/health-information/disorders/rett-syndrome" [X Link](https://x.com/TayshaGTx/status/1709321585826373879) 2023-10-03T21:36Z [---] followers, [---] engagements "We are proud to support the @OntarioRettSA's [----] Caregiver Conference. We look forward to connecting with members of the #Rettsyndrome community. This month we will be STRONGER TOGETHER at our Caregiver Conference thanks to @Tayshagenetherapies. Hope to see you there https://t.co/5woKG7STtr This month we will be STRONGER TOGETHER at our Caregiver Conference thanks to @Tayshagenetherapies. Hope to see you there https://t.co/5woKG7STtr" [X Link](https://x.com/TayshaGTx/status/1709922339155034154) 2023-10-05T13:23Z [---] followers, [---] engagements "We are excited to present data on our TSHA-102 #genetherapy program in evaluation for #Rettsyndrome at the #ESGCT2023 Annual Congress. Learn more about our upcoming poster presentations: https://bit.ly/3Q8kBCE https://bit.ly/3Q8kBCE" [X Link](https://x.com/TayshaGTx/status/1711714828920697145) 2023-10-10T12:06Z [---] followers, [---] engagements "Taysha is pleased to support the @Rettsyndromes Strollathon events to help fundraise advocate and accelerate research for #Rettsyndrome. Learn more: #RettSyndromeAwarenessMonth https://all-in.rettsyndrome.org/ https://all-in.rettsyndrome.org/" [X Link](https://x.com/TayshaGTx/status/1714395204415897906) 2023-10-17T21:37Z [---] followers, [---] engagements "We joined leading scientists clinicians and regulatory experts at @RSRT's first-ever Rett Syndrome Genetic Medicines Summit to help drive the conversation around the development of genetic medicine for #Rettsyndrome. Were proud to have supported this. https://bit.ly/3tuhNad https://bit.ly/3tuhNad" [X Link](https://x.com/TayshaGTx/status/1715061005787549858) 2023-10-19T17:43Z [---] followers, [---] engagements "This week at #ESGCT23 we present new preclinical in vitro data on TSHA-102 in #Rettsyndrome supporting the regulatory control of the miRARE technology. Learn more about the data and our continued development of TSHA-102: https://bit.ly/3MfvmAN https://bit.ly/3MfvmAN" [X Link](https://x.com/TayshaGTx/status/1716804130306445468) 2023-10-24T13:09Z [---] followers, [---] engagements "We had the pleasure of hearing from Paige Nues of @Rettsyndromes who shared her familys experience with #Rettsyndrome and her advocacy efforts with IRSF. Learn more about IRSFs mission: https://www.rettsyndrome.org/get-involved/raise-awareness/downloadable-resources/ https://www.rettsyndrome.org/get-involved/raise-awareness/downloadable-resources/" [X Link](https://x.com/TayshaGTx/status/1719394164066983981) 2023-10-31T16:41Z [---] followers, [---] engagements "Next week we will announce our third quarter [----] earnings and provide a corporate update. For more information visit: https://bit.ly/3u8BDbm https://bit.ly/3u8BDbm" [X Link](https://x.com/TayshaGTx/status/1721877241838067787) 2023-11-07T13:08Z [---] followers, [---] engagements "Were pleased to share Health Canada has authorized our protocol amendment that expands eligibility to include patients aged [--] and older with #Rettsyndrome in the REVEAL Phase 1/2 adult trial. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-expanded-eligibility-reveal https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-expanded-eligibility-reveal" [X Link](https://x.com/TayshaGTx/status/1729854988812210435) 2023-11-29T13:29Z [---] followers, [----] engagements "As #NationalFamilyCaregiversMonth ends we extend our ongoing support and recognition to those including Karen who care for individuals living with #Rettsyndrome. You are not alone. Learn more about our commitment to patients and caregivers: https://tayshagtx.com/patients-caregivers/ https://tayshagtx.com/patients-caregivers/" [X Link](https://x.com/TayshaGTx/status/1730261167354884409) 2023-11-30T16:23Z [---] followers, [---] engagements "Our President and Head of R&D Suku Nagendran MD discussed the high unmet need and evolving treatment landscape in #Rettsyndrome including the initial response from the first two adult patients dosed with TSHA-102 in our REVEAL Phase 1/2 trial https://www.cgtlive.com/view/sukumar-nagendran-addressing-unmet-needs-rett-syndrome-gene-therapy https://www.cgtlive.com/view/sukumar-nagendran-addressing-unmet-needs-rett-syndrome-gene-therapy" [X Link](https://x.com/TayshaGTx/status/1735713275516506130) 2023-12-15T17:27Z [---] followers, [---] engagements "We are pleased to share the first pediatric #Rettsyndrome patient was dosed with TSHA-102 in our REVEAL Phase 1/2 pediatric trial in the U.S. In addition the U.K. MHRA has accepted the Clinical Trial Application for TSHA-102 in pediatric patients. https://bit.ly/48sKPGz https://bit.ly/48sKPGz" [X Link](https://x.com/TayshaGTx/status/1745084008428363826) 2024-01-10T14:03Z [---] followers, [---] engagements "We look forward to presenting our previously disclosed clinical data from the first two adult #Rettsyndrome patients dosed with TSHA-102 in our REVEAL Phase 1/2 adolescent and adult trial at the #BPNA2024 Annual Conference. Learn more: https://bit.ly/3SpYCIy https://bit.ly/3SpYCIy" [X Link](https://x.com/TayshaGTx/status/1749418123634102411) 2024-01-22T13:05Z [---] followers, [---] engagements "Were counting down to #RareDiseaseDay on February [--] Get to know the faces of some of the individuals impacted by rare diseases as well as ways you can get involved on the @RareDiseases website: http://bit.ly/RDD2024 http://bit.ly/RDD2024" [X Link](https://x.com/TayshaGTx/status/1760784993024950723) 2024-02-22T21:53Z [---] followers, [---] engagements "We look forward to participating in #RareDiseaseDay at National Institutes of Health [----] on February [--]. Tune in to hear from our SVP of Clinical Development and Medical Affairs Meredith Schultz M.D. M.S.: https://ncats.nih.gov/news-events/events/rdd https://ncats.nih.gov/news-events/events/rdd" [X Link](https://x.com/TayshaGTx/status/1762908667148415432) 2024-02-28T18:32Z [---] followers, [---] engagements "We are pleased to share updates to our TSHA-102 program in clinical evaluation for the treatment of #Rettsyndrome: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-updates-tsha-102-clinical https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-updates-tsha-102-clinical" [X Link](https://x.com/TayshaGTx/status/1763212018671058969) 2024-02-29T14:37Z [---] followers, [---] engagements "We joined @RareDiseases #ShowYourStripes campaign to recognize #RareDiseaseDay. We were honored to hear from a family about their experience with #Rettsyndrome and the importance of raising awareness. Learn more about Rare Disease Day: http://bit.ly/RDD2024 http://bit.ly/RDD2024" [X Link](https://x.com/TayshaGTx/status/1765037924557729913) 2024-03-05T15:33Z [---] followers, [---] engagements "Were excited to share our refreshed website Check it out to learn more about our focus on #Rettsyndrome and how we are advancing AAV-based #genetherapies for severe monogenic diseases of the central nervous system. https://tayshagtx.com/ https://tayshagtx.com/" [X Link](https://x.com/TayshaGTx/status/1766097242207699250) 2024-03-08T13:42Z [---] followers, [---] engagements "Today we announced our full-year [----] earnings and provided updates on our TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-full-year-2023-financial-results https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-full-year-2023-financial-results" [X Link](https://x.com/TayshaGTx/status/1770179594148016290) 2024-03-19T20:04Z [---] followers, [----] engagements "Were pleased to share that the U.S. FDA has granted RMAT designation for TSHA-102 in Rett syndrome. This supports us on our mission to bring a potentially transformative #genetherapy to all patients and families living with #Rettsyndrome. $TSHA https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-regenerative-medicine-advanced https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-regenerative-medicine-advanced" [X Link](https://x.com/TayshaGTx/status/1786003114392244725) 2024-05-02T12:01Z [---] followers, [----] engagements "Next week we will announce our first quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2024-financial" [X Link](https://x.com/TayshaGTx/status/1787937443548705240) 2024-05-07T20:07Z [---] followers, [---] engagements "Were thrilled to share the recent promotion of Meredith Schultz M.D. M.S. to Chief Medical Officer and Rumana Haque-Ahmed to Chief Regulatory Officer. We look forward to their continued leadership. Congratulations on your well-deserved new roles" [X Link](https://x.com/TayshaGTx/status/1788615732751651061) 2024-05-09T17:03Z [---] followers, [---] engagements "Today we announced our first quarter [----] earnings and provided a corporate update. Read the release: $TSHA https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2024-financial" [X Link](https://x.com/TayshaGTx/status/1790473932450976164) 2024-05-14T20:07Z [---] followers, [---] engagements "Happy #ClinicalTrialsDay Today we recognize and thank the individuals and families who participate in clinical trials as well as those who lead and analyze the clinical research. Your contributions are critical to the development of new medicines. #CTD2024" [X Link](https://x.com/TayshaGTx/status/1792723612908356050) 2024-05-21T01:06Z [---] followers, [---] engagements "Join us June [--] for a live webcast as we discuss new clinical data from both of our REVEAL Phase 1/2 trials evaluating TSHA-102 in #Rettsyndrome. The data will also be presented at IRSFs @Rettsyndrome Scientific Meeting from June 18-19. Read more: $TSHA https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-present-clinical-data-both-reveal-phase-12 https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-present-clinical-data-both-reveal-phase-12" [X Link](https://x.com/TayshaGTx/status/1800846439758897385) 2024-06-12T11:03Z [---] followers, [---] engagements "Today we shared positive longer-term clinical data from the low dose cohort of our ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from our REVEAL Phase 1/2 pediatric trial evaluating TSHA-102 in #Rettsyndrome. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-positive-clinical-data-across https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-positive-clinical-data-across" [X Link](https://x.com/TayshaGTx/status/1803028625974841402) 2024-06-18T11:34Z [---] followers, [---] engagements "Last week at the ASCEND [----] @RettSyndrome National Summit we connected with families and advocates in the Rett community and engaged with medical experts in the field. Thank you IRSF for hosting another great meeting featuring research and advancements in #Rettsyndrome" [X Link](https://x.com/TayshaGTx/status/1806789533461024878) 2024-06-28T20:39Z [---] followers, [---] engagements "Next week we will announce our second quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2024-financial" [X Link](https://x.com/TayshaGTx/status/1820440515952734405) 2024-08-05T12:43Z [---] followers, [---] engagements "Today we reported our second quarter [----] earnings and provided a corporate update. Read the release: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2024-financial" [X Link](https://x.com/TayshaGTx/status/1822968056479400427) 2024-08-12T12:07Z [---] followers, [---] engagements "Were pleased to share our President and Head of R&D will be participating in a panel focused on How Investors See the Rare Space Now on October [--] at the #NORDsummit. See below for additional details and information on how to register to attend. What does the future of investment in #RareDisease treatments look like David Scheer will lead a panel discussion on this topic at this year's #NORDSummit featuring experts from @rallybio @TayshaGTx @SofinnovaVC & @OrbiMed Register here: https://t.co/IoFm543V0F https://t.co/sl02YUIrVk What does the future of investment in #RareDisease treatments look" [X Link](https://x.com/TayshaGTx/status/1833161011991363775) 2024-09-09T15:10Z [---] followers, [---] engagements "We're pleased to present previously disclosed clinical data from our ongoing REVEAL Phase 1/2 adolescent/adult trial and our REVEAL Phase 1/2 pediatric trial evaluating TSHA-102 in #Rettsyndrome at the upcoming #WorldRettSyndromeCongress. https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-oral-presentation-tsha-102-rett https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-oral-presentation-tsha-102-rett" [X Link](https://x.com/TayshaGTx/status/1839274737282806090) 2024-09-26T12:04Z [---] followers, [---] engagements "It's #RettSyndromeAwarenessMonth and were pleased to help raise awareness and support the patients and families living with #Rettsyndrome as we continue on our mission to bring a #genetherapy to the Rett syndrome community" [X Link](https://x.com/TayshaGTx/status/1841088259616563415) 2024-10-01T12:10Z [---] followers, [---] engagements "We look forward to presenting biodistribution data evaluating AAV9 #genetherapy delivery across five non-human primate studies at the #ESGCT2024 Annual Congress. Learn more about the upcoming presentation: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-present-biodistribution-data-analysis https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-present-biodistribution-data-analysis" [X Link](https://x.com/TayshaGTx/status/1848696241980330365) 2024-10-22T12:01Z [---] followers, [---] engagements "In recognition of #RettSyndromeAwarenessMonth we gathered for a viewing of Magnolias Hope a documentary following the Tesler familys journey with #RettSyndrome. Thank you @ajtesler and @magnoliashope for your continued dedication to raising awareness of Rett syndrome" [X Link](https://x.com/TayshaGTx/status/1851361295393517987) 2024-10-29T20:31Z [---] followers, [---] engagements "Taysha is pleased to support @Rettsyndromes Strollathon events to help fundraise advocate and accelerate research for #Rettsyndrome. Learn more: #RettSyndromeAwarenessMonth https://all-in.rettsyndrome.org/ https://all-in.rettsyndrome.org/" [X Link](https://x.com/TayshaGTx/status/1851980900633825353) 2024-10-31T13:33Z [---] followers, [---] engagements "Today we reported our third quarter [----] earnings and provided a corporate update. Read the release: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2024-financial" [X Link](https://x.com/TayshaGTx/status/1856810451209797943) 2024-11-13T21:24Z [---] followers, [---] engagements "Next week we will announce our full-year [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-full-year-2024-financial-results https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-full-year-2024-financial-results" [X Link](https://x.com/TayshaGTx/status/1892197964493300035) 2025-02-19T13:02Z [---] followers, [---] engagements "The countdown to #RareDiseaseDay is on The #TayshaTeam is proud to support the global initiative to raise awareness and generate support for those on a rare medical journey. Learn more about Rare Disease Day and how to get involved by visiting https://www.rarediseaseday.org https://www.rarediseaseday.org" [X Link](https://x.com/TayshaGTx/status/1894039589762875582) 2025-02-24T15:00Z [---] followers, [---] engagements "Today we announced our full-year [----] earnings and provided a corporate update. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-full-year-2024-financial-results https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-full-year-2024-financial-results" [X Link](https://x.com/TayshaGTx/status/1894737118032749046) 2025-02-26T13:11Z [---] followers, [---] engagements "On #RareDiseaseDay we heard from two #TayshaTeam members who shared their personal connection to #Rettsyndrome a rare neurodevelopmental disease and discussed the importance of raising awareness for individuals families & caregivers impacted by rare diseases. #ShowYourStripes" [X Link](https://x.com/TayshaGTx/status/1897026936339358060) 2025-03-04T20:50Z [---] followers, [---] engagements "We're a proud sponsor of @Rettsyndrome's new learning experience where families can learn more about #RettSyndrome research clinical trials and the future of #genetherapy. Congratulations to #IRSF on the launch of this exciting and educational program "Rett Forward: A Clinical Trial Master Class" will break down everything you need to know about Rett research & clinical trials. You're already Rett Research Ready; now let's move Rett Forward Module [--] drops later this month Brought to you thanks to @NeurogeneInc & @TayshaGTx. https://t.co/GqqAGkdrcI "Rett Forward: A Clinical Trial Master Class"" [X Link](https://x.com/anyuser/status/1915412316230688930) 2025-04-24T14:27Z [---] followers, [---] engagements "Congrats to Laura Sepp-Lorenzino PhD and Steven Gray PhD on their election to @ASGCTherapy's Board of Directors Were thrilled to see them share their expertise to help advance genetic and cellular therapies. https://www.asgct.org/publications/news/april-2025/new-board-members-2025 https://www.asgct.org/publications/news/april-2025/new-board-members-2025" [X Link](https://x.com/anyuser/status/1917285071519899850) 2025-04-29T18:29Z [---] followers, [---] engagements "Next week we will announce our first quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1920571398759620932) 2025-05-08T20:07Z [---] followers, [---] engagements "Today we reported our first quarter [----] earnings and provided a corporate update. Read the release: #genetherapy #Rettsyndrome https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1922987124581609910) 2025-05-15T12:07Z [---] followers, [---] engagements "Were pleased to share key elements of our pivotal Part B trial design for TSHA-102 in #Rettsyndrome enabled by @Rettsyndromes natural history dataset and positive clinical data from Part A of our REVEAL Phase 1/2 trials evaluating TSHA-102. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-pivotal-part-b-trial-design https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-pivotal-part-b-trial-design" [X Link](https://x.com/anyuser/status/1927817739923489009) 2025-05-28T20:02Z [---] followers, [----] engagements "Were thrilled to announce details for our upcoming oral presentations at the @rettsyndrome [----] International Rett Syndrome Foundation (RSF) Rett Syndrome Scientific Meeting Learn more about our presentations here: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-details-oral-presentations-2025 https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-details-oral-presentations-2025" [X Link](https://x.com/anyuser/status/1930020402207547877) 2025-06-03T21:54Z [---] followers, [---] engagements "Next week we will announce our second quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1952823706322919500) 2025-08-05T20:07Z [---] followers, [---] engagements "Today we reported our second quarter [----] earnings and provided a corporate update. Read the release: #genetherapy #Rettsyndrome https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1955239073758523481) 2025-08-12T12:04Z [---] followers, [---] engagements "Were pleased to announce our new supplemental data analysis from Part A of the REVEAL Phase 1/2 trials for TSHA-102 in #Rettsyndrome that further highlights the consistent multi-domain impact of TSHA-102 on activities of daily living. The analysis will be presented later today at the 54th Child Neurology Society Annual Meeting. Learn more: #CNSAM https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-presents-new-supplemental-data-analysis https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-presents-new-supplemental-data-analysis" [X Link](https://x.com/anyuser/status/1976257450517934239) 2025-10-09T12:04Z [---] followers, [---] engagements "Next week we will announce our third quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-third-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-third-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1983155553863176621) 2025-10-28T12:55Z [---] followers, [---] engagements "Taysha is pleased to be a sponsor of the International Rett Syndrome Foundations Strollathon events to help fundraise advocate and accelerate research for #Rettsyndrome. Throughout the month of October members of the #TayshaTeam were honored to join the Rett syndrome community in Strolls around the country to support IRSFs mission. #RettSyndromeAwarenessMonth @Rettsyndrome https://twitter.com/i/web/status/1983896674922803525 https://twitter.com/i/web/status/1983896674922803525" [X Link](https://x.com/anyuser/status/1983896674922803525) 2025-10-30T14:00Z [---] followers, [---] engagements "Taysha is proud to serve as a sponsor of @Rettsyndromes RettEd Days designed to provide educational resources and support to families affected by #Rettsyndrome. There are two more RettEd Days on the calendar in [----] and we hope to see you there Learn more: https://www.rettsyndrome.org/families/rett-education/retted-days/#retteddays-upcoming Registration is now open for our final RettEd Day of [----] with @BostonChildrens Join speakers including Professor Mriganka Sur from MIT clinic director Dr. David Liebermann and CPNP Grace Correa for a full day of programming. Learn more and register:" [X Link](https://x.com/anyuser/status/1958915198393221604) 2025-08-22T15:32Z [---] followers, [---] engagements "Last week Sean Nolan Tayshas CEO and Board Chairman and Fred Porter our Chief of Staff and Technical Operations Officer joined industry leaders at the [----] @Official_Cantor Global Healthcare Conference to discuss company updates and highlight progress on our lead TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome. Learn more about our approach: https://tayshagtx.com/pipeline/ https://tayshagtx.com/pipeline/" [X Link](https://x.com/anyuser/status/1966490973497659596) 2025-09-12T13:15Z [---] followers, [---] engagements "It's #RettSyndromeAwarenessMonth and were proud to help raise awareness and support the individuals and families impacted by #Rettsyndrome as we continue our mission to bring a #genetherapy to the Rett syndrome community" [X Link](https://x.com/anyuser/status/1973379906491875685) 2025-10-01T13:30Z [---] followers, [---] engagements "Today we announced exciting regulatory updates on our TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome supporting the path toward potential registration: - The U.S. FDA granted Breakthrough Therapy designation to TSHA-102 - We reached final alignment with the FDA on all aspects of our REVEAL pivotal trial protocol and statistical analysis plan that are intended to support our planned Biologics License Application submission for TSHA-102 Read the release to learn more:" [X Link](https://x.com/anyuser/status/1973722303633445017) 2025-10-02T12:10Z [---] followers, [---] engagements "Next week Sean Nolan our Chairman and CEO will serve as a panelist during the Special Plenary session taking place Monday October [--] at the @RareDiseases National Organization for Rare Disorders Rare Diseases and Orphan Products Breakthrough Summit. The panel will be comprised of #biotech leaders investors and entrepreneurs who will share their perspectives on the outlook for #raredisease investment in [----] and beyond. How are #biotech and #pharma leaders meeting the moment for #RareDisease patients Hear from CEOs and senior leaders at the [----] NORD Breakthrough Summit about newborn screening" [X Link](https://x.com/anyuser/status/1978119961110311260) 2025-10-14T15:25Z [---] followers, [---] engagements "Today we reported our third quarter [----] earnings and provided a corporate update. Were pleased with the progress made across our lead TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome in support of our path to potential registration. Read the release to learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1985679399425872364) 2025-11-04T12:03Z [---] followers, [---] engagements "Werecounting down toRare Disease DayRecognized on the last day of February each year#RareDiseaseDay is a global initiative to raise awareness and generate support for everyone on a rare medical journey. Learn more about @rarediseaseday and how to get involved by https://www.rarediseaseday.org/ https://www.rarediseaseday.org/" [X Link](https://x.com/anyuser/status/2021327047134453866) 2026-02-10T20:54Z [---] followers, [--] engagements "Today we announced that the first patient was dosed in our REVEAL pivotal trial in Q4 [----] and that weve reached written alignment with the U.S. FDA on our ASPIRE safety-focused trial and the data for inclusion in our planned BLA submission to support a broad label for TSHA-102 for patients aged [--] years with #Rettsyndrome. Read the release to learn more about the progress across our TSHA-102 #genetherapy program in clinical evaluation for Rett syndrome: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-progress-across-tsha-102-pivotal" [X Link](https://x.com/anyuser/status/2008525145187483851) 2026-01-06T13:04Z [---] followers, [---] engagements "Today we reported our third quarter [----] earnings and provided a corporate update. Were pleased with the progress made across our lead TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome in support of our path to potential registration. Read the release to learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1985679399425872364) 2025-11-04T12:03Z [---] followers, [---] engagements "Taysha is pleased to be a sponsor of the International Rett Syndrome Foundations Strollathon events to help fundraise advocate and accelerate research for #Rettsyndrome. Throughout the month of October members of the #TayshaTeam were honored to join the Rett syndrome community in Strolls around the country to support IRSFs mission. #RettSyndromeAwarenessMonth @Rettsyndrome https://twitter.com/i/web/status/1983896674922803525 https://twitter.com/i/web/status/1983896674922803525" [X Link](https://x.com/anyuser/status/1983896674922803525) 2025-10-30T14:00Z [---] followers, [---] engagements "Next week we will announce our third quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-third-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-third-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1983155553863176621) 2025-10-28T12:55Z [---] followers, [---] engagements "In recognition of #RettSyndromeAwarenessMonth the Taysha team had the privilege of meeting Kelsey and her daughter Molly who lives with #Rettsyndrome. Kelsey shared her familys journey with Rett syndrome and offered her perspective on what meaningful progress toward a treatment would look like. We are grateful to Kelsey for sharing her story and for her unwavering dedication to raising awareness of Rett syndrome. We also joined the International Rett Syndrome Foundations 2nd annual #PurpleOut in support of families impacted by Rett syndrome @RettSyndrome" [X Link](https://x.com/anyuser/status/1981016312668426740) 2025-10-22T15:14Z [---] followers, [---] engagements "Next week Sean Nolan our Chairman and CEO will serve as a panelist during the Special Plenary session taking place Monday October [--] at the @RareDiseases National Organization for Rare Disorders Rare Diseases and Orphan Products Breakthrough Summit. The panel will be comprised of #biotech leaders investors and entrepreneurs who will share their perspectives on the outlook for #raredisease investment in [----] and beyond. How are #biotech and #pharma leaders meeting the moment for #RareDisease patients Hear from CEOs and senior leaders at the [----] NORD Breakthrough Summit about newborn screening" [X Link](https://x.com/anyuser/status/1978119961110311260) 2025-10-14T15:25Z [---] followers, [---] engagements "How are #biotech and #pharma leaders meeting the moment for #RareDisease patients Hear from CEOs and senior leaders at the [----] NORD Breakthrough Summit about newborn screening curative therapies and strategic collaboration. Register now: 🔑 @AcadiaPharma @MPSSociety @TayshaGTx @TheMightySite https://bit.ly/4lSAkDq https://bit.ly/4lSAkDq" [X Link](https://x.com/anyuser/status/1968029399787188226) 2025-09-16T19:09Z 39.8K followers, [---] engagements "Were pleased to announce our new supplemental data analysis from Part A of the REVEAL Phase 1/2 trials for TSHA-102 in #Rettsyndrome that further highlights the consistent multi-domain impact of TSHA-102 on activities of daily living. The analysis will be presented later today at the 54th Child Neurology Society Annual Meeting. Learn more: #CNSAM https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-presents-new-supplemental-data-analysis https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-presents-new-supplemental-data-analysis" [X Link](https://x.com/anyuser/status/1976257450517934239) 2025-10-09T12:04Z [---] followers, [---] engagements "Today we announced exciting regulatory updates on our TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome supporting the path toward potential registration: - The U.S. FDA granted Breakthrough Therapy designation to TSHA-102 - We reached final alignment with the FDA on all aspects of our REVEAL pivotal trial protocol and statistical analysis plan that are intended to support our planned Biologics License Application submission for TSHA-102 Read the release to learn more:" [X Link](https://x.com/anyuser/status/1973722303633445017) 2025-10-02T12:10Z [---] followers, [---] engagements "It's #RettSyndromeAwarenessMonth and were proud to help raise awareness and support the individuals and families impacted by #Rettsyndrome as we continue our mission to bring a #genetherapy to the Rett syndrome community" [X Link](https://x.com/anyuser/status/1973379906491875685) 2025-10-01T13:30Z [---] followers, [---] engagements "Last week Sean Nolan Tayshas CEO and Board Chairman and Fred Porter our Chief of Staff and Technical Operations Officer joined industry leaders at the [----] @Official_Cantor Global Healthcare Conference to discuss company updates and highlight progress on our lead TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome. Learn more about our approach: https://tayshagtx.com/pipeline/ https://tayshagtx.com/pipeline/" [X Link](https://x.com/anyuser/status/1966490973497659596) 2025-09-12T13:15Z [---] followers, [---] engagements "Taysha is proud to serve as a sponsor of @Rettsyndromes RettEd Days designed to provide educational resources and support to families affected by #Rettsyndrome. There are two more RettEd Days on the calendar in [----] and we hope to see you there Learn more: https://www.rettsyndrome.org/families/rett-education/retted-days/#retteddays-upcoming Registration is now open for our final RettEd Day of [----] with @BostonChildrens Join speakers including Professor Mriganka Sur from MIT clinic director Dr. David Liebermann and CPNP Grace Correa for a full day of programming. Learn more and register:" [X Link](https://x.com/anyuser/status/1958915198393221604) 2025-08-22T15:32Z [---] followers, [---] engagements "Registration is now open for our final RettEd Day of [----] with @BostonChildrens Join speakers including Professor Mriganka Sur from MIT clinic director Dr. David Liebermann and CPNP Grace Correa for a full day of programming. Learn more and register: http://rettsyndrome.org/retted-bch25 http://rettsyndrome.org/retted-bch25" [X Link](https://x.com/anyuser/status/1950194699697832014) 2025-07-29T14:00Z [----] followers, [---] engagements "Today we reported our second quarter [----] earnings and provided a corporate update. Read the release: #genetherapy #Rettsyndrome https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1955239073758523481) 2025-08-12T12:04Z [---] followers, [---] engagements "Next week we will announce our second quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1952823706322919500) 2025-08-05T20:07Z [---] followers, [---] engagements "Were thrilled to announce details for our upcoming oral presentations at the @rettsyndrome [----] International Rett Syndrome Foundation (RSF) Rett Syndrome Scientific Meeting Learn more about our presentations here: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-details-oral-presentations-2025 https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-details-oral-presentations-2025" [X Link](https://x.com/anyuser/status/1930020402207547877) 2025-06-03T21:54Z [---] followers, [---] engagements "Were pleased to share key elements of our pivotal Part B trial design for TSHA-102 in #Rettsyndrome enabled by @Rettsyndromes natural history dataset and positive clinical data from Part A of our REVEAL Phase 1/2 trials evaluating TSHA-102. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-pivotal-part-b-trial-design https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-pivotal-part-b-trial-design" [X Link](https://x.com/anyuser/status/1927817739923489009) 2025-05-28T20:02Z [---] followers, [----] engagements "Today we reported our first quarter [----] earnings and provided a corporate update. Read the release: #genetherapy #Rettsyndrome https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1922987124581609910) 2025-05-15T12:07Z [---] followers, [---] engagements "Next week we will announce our first quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2025-financial" [X Link](https://x.com/anyuser/status/1920571398759620932) 2025-05-08T20:07Z [---] followers, [---] engagements "Congrats to Laura Sepp-Lorenzino PhD and Steven Gray PhD on their election to @ASGCTherapy's Board of Directors Were thrilled to see them share their expertise to help advance genetic and cellular therapies. https://www.asgct.org/publications/news/april-2025/new-board-members-2025 https://www.asgct.org/publications/news/april-2025/new-board-members-2025" [X Link](https://x.com/anyuser/status/1917285071519899850) 2025-04-29T18:29Z [---] followers, [---] engagements "We're a proud sponsor of @Rettsyndrome's new learning experience where families can learn more about #RettSyndrome research clinical trials and the future of #genetherapy. Congratulations to #IRSF on the launch of this exciting and educational program "Rett Forward: A Clinical Trial Master Class" will break down everything you need to know about Rett research & clinical trials. You're already Rett Research Ready; now let's move Rett Forward Module [--] drops later this month Brought to you thanks to @NeurogeneInc & @TayshaGTx. https://t.co/GqqAGkdrcI "Rett Forward: A Clinical Trial Master Class"" [X Link](https://x.com/anyuser/status/1915412316230688930) 2025-04-24T14:27Z [---] followers, [---] engagements ""Rett Forward: A Clinical Trial Master Class" will break down everything you need to know about Rett research & clinical trials. You're already Rett Research Ready; now let's move Rett Forward Module [--] drops later this month Brought to you thanks to @NeurogeneInc & @TayshaGTx" [X Link](https://x.com/anyuser/status/1914680826102493228) 2025-04-22T14:00Z [----] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@TayshaGTx Taysha Gene TherapiesTaysha Gene Therapies posts on X about share, $tsha, fda, events the most. They currently have [---] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.
Social category influence countries finance
Social topic influence share, $tsha, fda, events, community, ceo, protocol, ready, break, director
Top accounts mentioned or mentioned by @rettsyndromes @rettsyndrome @rarediseases @neurogeneinc @bostonchildrens @asgctherapys @officialcantor @asgctherapy @ontariorettsas @tayshagenetherapies @rsrts @rallybio @sofinnovavc @orbimed @ajtesler @magnoliashope @rarediseaseday @acadiapharma @mpssociety @themightysite
Top assets mentioned Taysha Gene Therapies, Inc. (TSHA)
Top posts by engagements in the last [--] hours
"July is #FragileXSyndrome Awareness Month. #FXS is the most common single gene cause of autism and cognitive impairment affecting 100K individuals globally. This disease is diagnosed around [--] years old and is characterized in many ways"
X Link 2021-07-02T16:44Z [---] followers, [--] engagements
"Wishing you a Happy New Year from all of us at Taysha Gene Therapies"
X Link 2023-01-01T16:55Z [---] followers, [---] engagements
"Hear from Sarah Davenport CPA our Corporate Controller on what inspires her as a #RareAlly"
X Link 2023-01-11T17:24Z [---] followers, [---] engagements
"#RareDiseaseDay is right around the corner and all month long our team is raising awareness for #raredisease including those that are genetic and affecting children as early as birth. Join us as we #ShowYourStripes and #CareAboutRare"
X Link 2023-02-08T17:43Z [---] followers, [---] engagements
"Worldwide people live with rare disease and the impact goes beyond health itself as its felt in many aspects of a persons life. At #TayshaGeneTherapies we raise awareness of the 7K+ #rarediseases & show support for the millions of people living with a rare disease. #RareAlly"
X Link 2023-02-09T18:10Z [---] followers, [---] engagements
"The FDA is hosting Rare Disease Day a virtual public meeting on February 27th - registration is free and open to the public Learn more at https://bit.ly/FDARareDiseaseDay https://bit.ly/FDARareDiseaseDay"
X Link 2023-02-16T00:29Z [---] followers, [---] engagements
"We asked Dr. Nagendran Tayshas new President and Head of Research & Development what has inspired him in drug development in rare diseases. #RareDiseaseDay #RareAlly"
X Link 2023-02-16T20:34Z [---] followers, [---] engagements
"Chief Corporate Affairs Officer Kim Lee reflects on how collective efforts from the rare disease communities are instrumental in the daily work at Taysha. #RareAlly"
X Link 2023-02-21T18:37Z [---] followers, [---] engagements
"#RareDiseaseDay is an opportunity for us to honor the unique differences & strength of the entire #raredisease community that inspire us daily. No matter where you are in the world today brings us together as a #RareAlly #Taysha"
X Link 2023-02-28T22:24Z [---] followers, [---] engagements
"Today we announced our fourth quarter and full year [----] earnings. Learn more: http://bit.ly/3M2fylt http://bit.ly/3M2fylt"
X Link 2023-03-28T20:06Z [---] followers, [---] engagements
"We are excited to announce new preclinical data for our TSHA-102 #genetherapy program in evaluation for Rett Syndrome will be presented at the #ASGCT23 Annual Meeting on May [--]. Learn more: https://bit.ly/3NlrD66 https://bit.ly/3NlrD66"
X Link 2023-04-27T21:04Z [---] followers, [---] engagements
"Next week we will announce our first quarter [----] earnings and provide a corporate update. For more information visit: https://bit.ly/3I1MNTp https://bit.ly/3I1MNTp"
X Link 2023-05-04T12:26Z [---] followers, [---] engagements
"Today we announced our first quarter [----] earnings. Learn more: https://bit.ly/3LRbrae https://bit.ly/3LRbrae"
X Link 2023-05-11T20:04Z [---] followers, [---] engagements
"This week at #ASGCT23 we present new preclinical data that supports the continued development of our TSHA-102 #genetherapy program in evaluation for Rett Syndrome. Learn more: https://bit.ly/3IpDywc https://bit.ly/3IpDywc"
X Link 2023-05-19T12:22Z [---] followers, [---] engagements
"We are excited to participate in the @Rettsyndromes [----] IRSF Rett Syndrome Scientific Meeting. We look forward to sharing updates on our investigational TSHA-102 program and research on caregiver perspectives of #genetherapy clinical trials during upcoming presentations"
X Link 2023-06-02T18:36Z [---] followers, [---] engagements
"We are excited to announce the first patient has been dosed in the REVEAL Phase 1/2 trial evaluating our investigational AAV9 #genetherapy for #Rettsyndrome. Learn more: https://bit.ly/3MPlk8T https://bit.ly/3MPlk8T"
X Link 2023-06-05T12:35Z [---] followers, [---] engagements
"Looking forward to sharing updates on our investigational programs in evaluation for Rett syndrome and giant axonal neuropathy (GAN) at our upcoming R&D Day. Register here: https://lifesci.events/Taysha Join us on June [--] at 10am ET for a Virtual R&D Day with @TayshaGTx featuring Salman Bhai MD discussing updates for TSHA-120 being investigated in giant axonal neuropathy (GAN) and TSHA-102 being investigated in Rett syndrome. $TSHA Register here: https://t.co/GV3n0WNzpE https://t.co/NnSOkdL00T https://lifesci.events/Taysha Join us on June [--] at 10am ET for a Virtual R&D Day with @TayshaGTx"
X Link 2023-06-08T16:45Z [---] followers, [---] engagements
"Our President and Head of R&D Suku Nagendran M.D. and his wife Ann created the Jerry Mendell Award for Translational Science in partnership with @ASGCTherapy to help the next generation of scientists develop #genetherapies. Congratulations to the [----] recipients. ASGCT is grateful to member Suku Nagendran MD (@TayshaGTX) and his wife Ann for their generous giftfunding the Jerry Mendell award in perpetuity to encourage #genetherapy development. https://t.co/MtJY6ce3AV https://t.co/VLVXgFfDzO ASGCT is grateful to member Suku Nagendran MD (@TayshaGTX) and his wife Ann for their generous"
X Link 2023-06-13T16:20Z [---] followers, [---] engagements
"We look forward to discussing updates on our investigational #genetherapy programs for Rett syndrome and giant axonal neuropathy (GAN) at our virtual R&D Day on June [--]. Learn more about the event and register today: https://bit.ly/3p7eP9E https://bit.ly/3p7eP9E"
X Link 2023-06-15T12:10Z [---] followers, [---] engagements
"Dont forget tune in to our virtual R&D Day today at [--] a.m. ET to hear the latest in the development of our investigational #genetherapies in giant axonal neuropathy (GAN) and Rett syndrome. https://bit.ly/3NPTiM3 https://bit.ly/3NPTiM3"
X Link 2023-06-28T12:08Z [---] followers, [---] engagements
"Were pleased to share the IDMC recommended the continuation of the REVEAL Phase 1/2 trial evaluating TSHA-102 in adults with #RettSyndrome. Learn more: https://bit.ly/458bc2x https://bit.ly/458bc2x"
X Link 2023-07-31T12:20Z [---] followers, [----] engagements
"Today we announced a $150 million private placement financing. We are pleased by the support from new and existing investors and believe we are well positioned to continue to execute across key program milestones. Learn more: https://bit.ly/3DW1pRO https://bit.ly/3DW1pRO"
X Link 2023-08-14T14:22Z [---] followers, [---] engagements
"We announced our second quarter [----] earnings today and provided updates including the initial clinical data from the first adult #Rettsyndrome patient dosed in the REVEAL Phase 1/2 trial. #genetherapy Learn more: https://bit.ly/3KFzWHP https://bit.ly/3KFzWHP"
X Link 2023-08-14T15:47Z [---] followers, [----] engagements
"The U.S. FDA granted Fast Track Designation to TSHA-102 our investigational #genetherapy in clinical evaluation for #Rettsyndrome. Learn more: https://bit.ly/3OM3Dbb https://bit.ly/3OM3Dbb"
X Link 2023-08-24T12:06Z [---] followers, [---] engagements
"We are pleased to announce the second adult patient has been dosed in the REVEAL Phase 1/2 trial evaluating TSHA-102 in #Rettsyndrome. Learn more: #genetherapy https://bit.ly/3rsWkO4 https://bit.ly/3rsWkO4"
X Link 2023-09-26T12:08Z [---] followers, [---] engagements
"This week we joined industry leaders at the [----] Cantor Global Healthcare Conference to discuss company updates and the latest developments shaping the #genetherapy landscape. Learn more about our approach: https://tayshagtx.com/approach/ https://tayshagtx.com/approach/"
X Link 2023-09-28T23:58Z [---] followers, [---] engagements
"October is #RettSyndromeAwarenessMonth and were proud to join the Rett syndrome community in raising awareness of #Rettsyndrome a rare neurodevelopmental disorder caused by mutations in the MECP2 gene. Learn more: https://www.ninds.nih.gov/health-information/disorders/rett-syndrome https://www.ninds.nih.gov/health-information/disorders/rett-syndrome"
X Link 2023-10-03T21:36Z [---] followers, [---] engagements
"We are proud to support the @OntarioRettSA's [----] Caregiver Conference. We look forward to connecting with members of the #Rettsyndrome community. This month we will be STRONGER TOGETHER at our Caregiver Conference thanks to @Tayshagenetherapies. Hope to see you there https://t.co/5woKG7STtr This month we will be STRONGER TOGETHER at our Caregiver Conference thanks to @Tayshagenetherapies. Hope to see you there https://t.co/5woKG7STtr"
X Link 2023-10-05T13:23Z [---] followers, [---] engagements
"We are excited to present data on our TSHA-102 #genetherapy program in evaluation for #Rettsyndrome at the #ESGCT2023 Annual Congress. Learn more about our upcoming poster presentations: https://bit.ly/3Q8kBCE https://bit.ly/3Q8kBCE"
X Link 2023-10-10T12:06Z [---] followers, [---] engagements
"Taysha is pleased to support the @Rettsyndromes Strollathon events to help fundraise advocate and accelerate research for #Rettsyndrome. Learn more: #RettSyndromeAwarenessMonth https://all-in.rettsyndrome.org/ https://all-in.rettsyndrome.org/"
X Link 2023-10-17T21:37Z [---] followers, [---] engagements
"We joined leading scientists clinicians and regulatory experts at @RSRT's first-ever Rett Syndrome Genetic Medicines Summit to help drive the conversation around the development of genetic medicine for #Rettsyndrome. Were proud to have supported this. https://bit.ly/3tuhNad https://bit.ly/3tuhNad"
X Link 2023-10-19T17:43Z [---] followers, [---] engagements
"This week at #ESGCT23 we present new preclinical in vitro data on TSHA-102 in #Rettsyndrome supporting the regulatory control of the miRARE technology. Learn more about the data and our continued development of TSHA-102: https://bit.ly/3MfvmAN https://bit.ly/3MfvmAN"
X Link 2023-10-24T13:09Z [---] followers, [---] engagements
"We had the pleasure of hearing from Paige Nues of @Rettsyndromes who shared her familys experience with #Rettsyndrome and her advocacy efforts with IRSF. Learn more about IRSFs mission: https://www.rettsyndrome.org/get-involved/raise-awareness/downloadable-resources/ https://www.rettsyndrome.org/get-involved/raise-awareness/downloadable-resources/"
X Link 2023-10-31T16:41Z [---] followers, [---] engagements
"Next week we will announce our third quarter [----] earnings and provide a corporate update. For more information visit: https://bit.ly/3u8BDbm https://bit.ly/3u8BDbm"
X Link 2023-11-07T13:08Z [---] followers, [---] engagements
"Were pleased to share Health Canada has authorized our protocol amendment that expands eligibility to include patients aged [--] and older with #Rettsyndrome in the REVEAL Phase 1/2 adult trial. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-expanded-eligibility-reveal https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-expanded-eligibility-reveal"
X Link 2023-11-29T13:29Z [---] followers, [----] engagements
"As #NationalFamilyCaregiversMonth ends we extend our ongoing support and recognition to those including Karen who care for individuals living with #Rettsyndrome. You are not alone. Learn more about our commitment to patients and caregivers: https://tayshagtx.com/patients-caregivers/ https://tayshagtx.com/patients-caregivers/"
X Link 2023-11-30T16:23Z [---] followers, [---] engagements
"Our President and Head of R&D Suku Nagendran MD discussed the high unmet need and evolving treatment landscape in #Rettsyndrome including the initial response from the first two adult patients dosed with TSHA-102 in our REVEAL Phase 1/2 trial https://www.cgtlive.com/view/sukumar-nagendran-addressing-unmet-needs-rett-syndrome-gene-therapy https://www.cgtlive.com/view/sukumar-nagendran-addressing-unmet-needs-rett-syndrome-gene-therapy"
X Link 2023-12-15T17:27Z [---] followers, [---] engagements
"We are pleased to share the first pediatric #Rettsyndrome patient was dosed with TSHA-102 in our REVEAL Phase 1/2 pediatric trial in the U.S. In addition the U.K. MHRA has accepted the Clinical Trial Application for TSHA-102 in pediatric patients. https://bit.ly/48sKPGz https://bit.ly/48sKPGz"
X Link 2024-01-10T14:03Z [---] followers, [---] engagements
"We look forward to presenting our previously disclosed clinical data from the first two adult #Rettsyndrome patients dosed with TSHA-102 in our REVEAL Phase 1/2 adolescent and adult trial at the #BPNA2024 Annual Conference. Learn more: https://bit.ly/3SpYCIy https://bit.ly/3SpYCIy"
X Link 2024-01-22T13:05Z [---] followers, [---] engagements
"Were counting down to #RareDiseaseDay on February [--] Get to know the faces of some of the individuals impacted by rare diseases as well as ways you can get involved on the @RareDiseases website: http://bit.ly/RDD2024 http://bit.ly/RDD2024"
X Link 2024-02-22T21:53Z [---] followers, [---] engagements
"We look forward to participating in #RareDiseaseDay at National Institutes of Health [----] on February [--]. Tune in to hear from our SVP of Clinical Development and Medical Affairs Meredith Schultz M.D. M.S.: https://ncats.nih.gov/news-events/events/rdd https://ncats.nih.gov/news-events/events/rdd"
X Link 2024-02-28T18:32Z [---] followers, [---] engagements
"We are pleased to share updates to our TSHA-102 program in clinical evaluation for the treatment of #Rettsyndrome: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-updates-tsha-102-clinical https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-updates-tsha-102-clinical"
X Link 2024-02-29T14:37Z [---] followers, [---] engagements
"We joined @RareDiseases #ShowYourStripes campaign to recognize #RareDiseaseDay. We were honored to hear from a family about their experience with #Rettsyndrome and the importance of raising awareness. Learn more about Rare Disease Day: http://bit.ly/RDD2024 http://bit.ly/RDD2024"
X Link 2024-03-05T15:33Z [---] followers, [---] engagements
"Were excited to share our refreshed website Check it out to learn more about our focus on #Rettsyndrome and how we are advancing AAV-based #genetherapies for severe monogenic diseases of the central nervous system. https://tayshagtx.com/ https://tayshagtx.com/"
X Link 2024-03-08T13:42Z [---] followers, [---] engagements
"Today we announced our full-year [----] earnings and provided updates on our TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-full-year-2023-financial-results https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-full-year-2023-financial-results"
X Link 2024-03-19T20:04Z [---] followers, [----] engagements
"Were pleased to share that the U.S. FDA has granted RMAT designation for TSHA-102 in Rett syndrome. This supports us on our mission to bring a potentially transformative #genetherapy to all patients and families living with #Rettsyndrome. $TSHA https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-regenerative-medicine-advanced https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-regenerative-medicine-advanced"
X Link 2024-05-02T12:01Z [---] followers, [----] engagements
"Next week we will announce our first quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2024-financial"
X Link 2024-05-07T20:07Z [---] followers, [---] engagements
"Were thrilled to share the recent promotion of Meredith Schultz M.D. M.S. to Chief Medical Officer and Rumana Haque-Ahmed to Chief Regulatory Officer. We look forward to their continued leadership. Congratulations on your well-deserved new roles"
X Link 2024-05-09T17:03Z [---] followers, [---] engagements
"Today we announced our first quarter [----] earnings and provided a corporate update. Read the release: $TSHA https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2024-financial"
X Link 2024-05-14T20:07Z [---] followers, [---] engagements
"Happy #ClinicalTrialsDay Today we recognize and thank the individuals and families who participate in clinical trials as well as those who lead and analyze the clinical research. Your contributions are critical to the development of new medicines. #CTD2024"
X Link 2024-05-21T01:06Z [---] followers, [---] engagements
"Join us June [--] for a live webcast as we discuss new clinical data from both of our REVEAL Phase 1/2 trials evaluating TSHA-102 in #Rettsyndrome. The data will also be presented at IRSFs @Rettsyndrome Scientific Meeting from June 18-19. Read more: $TSHA https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-present-clinical-data-both-reveal-phase-12 https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-present-clinical-data-both-reveal-phase-12"
X Link 2024-06-12T11:03Z [---] followers, [---] engagements
"Today we shared positive longer-term clinical data from the low dose cohort of our ongoing REVEAL Phase 1/2 adolescent and adult trial and initial clinical data from our REVEAL Phase 1/2 pediatric trial evaluating TSHA-102 in #Rettsyndrome. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-positive-clinical-data-across https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-positive-clinical-data-across"
X Link 2024-06-18T11:34Z [---] followers, [---] engagements
"Last week at the ASCEND [----] @RettSyndrome National Summit we connected with families and advocates in the Rett community and engaged with medical experts in the field. Thank you IRSF for hosting another great meeting featuring research and advancements in #Rettsyndrome"
X Link 2024-06-28T20:39Z [---] followers, [---] engagements
"Next week we will announce our second quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2024-financial"
X Link 2024-08-05T12:43Z [---] followers, [---] engagements
"Today we reported our second quarter [----] earnings and provided a corporate update. Read the release: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2024-financial"
X Link 2024-08-12T12:07Z [---] followers, [---] engagements
"Were pleased to share our President and Head of R&D will be participating in a panel focused on How Investors See the Rare Space Now on October [--] at the #NORDsummit. See below for additional details and information on how to register to attend. What does the future of investment in #RareDisease treatments look like David Scheer will lead a panel discussion on this topic at this year's #NORDSummit featuring experts from @rallybio @TayshaGTx @SofinnovaVC & @OrbiMed Register here: https://t.co/IoFm543V0F https://t.co/sl02YUIrVk What does the future of investment in #RareDisease treatments look"
X Link 2024-09-09T15:10Z [---] followers, [---] engagements
"We're pleased to present previously disclosed clinical data from our ongoing REVEAL Phase 1/2 adolescent/adult trial and our REVEAL Phase 1/2 pediatric trial evaluating TSHA-102 in #Rettsyndrome at the upcoming #WorldRettSyndromeCongress. https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-oral-presentation-tsha-102-rett https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-oral-presentation-tsha-102-rett"
X Link 2024-09-26T12:04Z [---] followers, [---] engagements
"It's #RettSyndromeAwarenessMonth and were pleased to help raise awareness and support the patients and families living with #Rettsyndrome as we continue on our mission to bring a #genetherapy to the Rett syndrome community"
X Link 2024-10-01T12:10Z [---] followers, [---] engagements
"We look forward to presenting biodistribution data evaluating AAV9 #genetherapy delivery across five non-human primate studies at the #ESGCT2024 Annual Congress. Learn more about the upcoming presentation: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-present-biodistribution-data-analysis https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-present-biodistribution-data-analysis"
X Link 2024-10-22T12:01Z [---] followers, [---] engagements
"In recognition of #RettSyndromeAwarenessMonth we gathered for a viewing of Magnolias Hope a documentary following the Tesler familys journey with #RettSyndrome. Thank you @ajtesler and @magnoliashope for your continued dedication to raising awareness of Rett syndrome"
X Link 2024-10-29T20:31Z [---] followers, [---] engagements
"Taysha is pleased to support @Rettsyndromes Strollathon events to help fundraise advocate and accelerate research for #Rettsyndrome. Learn more: #RettSyndromeAwarenessMonth https://all-in.rettsyndrome.org/ https://all-in.rettsyndrome.org/"
X Link 2024-10-31T13:33Z [---] followers, [---] engagements
"Today we reported our third quarter [----] earnings and provided a corporate update. Read the release: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2024-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2024-financial"
X Link 2024-11-13T21:24Z [---] followers, [---] engagements
"Next week we will announce our full-year [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-full-year-2024-financial-results https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-full-year-2024-financial-results"
X Link 2025-02-19T13:02Z [---] followers, [---] engagements
"The countdown to #RareDiseaseDay is on The #TayshaTeam is proud to support the global initiative to raise awareness and generate support for those on a rare medical journey. Learn more about Rare Disease Day and how to get involved by visiting https://www.rarediseaseday.org https://www.rarediseaseday.org"
X Link 2025-02-24T15:00Z [---] followers, [---] engagements
"Today we announced our full-year [----] earnings and provided a corporate update. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-full-year-2024-financial-results https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-full-year-2024-financial-results"
X Link 2025-02-26T13:11Z [---] followers, [---] engagements
"On #RareDiseaseDay we heard from two #TayshaTeam members who shared their personal connection to #Rettsyndrome a rare neurodevelopmental disease and discussed the importance of raising awareness for individuals families & caregivers impacted by rare diseases. #ShowYourStripes"
X Link 2025-03-04T20:50Z [---] followers, [---] engagements
"We're a proud sponsor of @Rettsyndrome's new learning experience where families can learn more about #RettSyndrome research clinical trials and the future of #genetherapy. Congratulations to #IRSF on the launch of this exciting and educational program "Rett Forward: A Clinical Trial Master Class" will break down everything you need to know about Rett research & clinical trials. You're already Rett Research Ready; now let's move Rett Forward Module [--] drops later this month Brought to you thanks to @NeurogeneInc & @TayshaGTx. https://t.co/GqqAGkdrcI "Rett Forward: A Clinical Trial Master Class""
X Link 2025-04-24T14:27Z [---] followers, [---] engagements
"Congrats to Laura Sepp-Lorenzino PhD and Steven Gray PhD on their election to @ASGCTherapy's Board of Directors Were thrilled to see them share their expertise to help advance genetic and cellular therapies. https://www.asgct.org/publications/news/april-2025/new-board-members-2025 https://www.asgct.org/publications/news/april-2025/new-board-members-2025"
X Link 2025-04-29T18:29Z [---] followers, [---] engagements
"Next week we will announce our first quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2025-financial"
X Link 2025-05-08T20:07Z [---] followers, [---] engagements
"Today we reported our first quarter [----] earnings and provided a corporate update. Read the release: #genetherapy #Rettsyndrome https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2025-financial"
X Link 2025-05-15T12:07Z [---] followers, [---] engagements
"Were pleased to share key elements of our pivotal Part B trial design for TSHA-102 in #Rettsyndrome enabled by @Rettsyndromes natural history dataset and positive clinical data from Part A of our REVEAL Phase 1/2 trials evaluating TSHA-102. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-pivotal-part-b-trial-design https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-pivotal-part-b-trial-design"
X Link 2025-05-28T20:02Z [---] followers, [----] engagements
"Were thrilled to announce details for our upcoming oral presentations at the @rettsyndrome [----] International Rett Syndrome Foundation (RSF) Rett Syndrome Scientific Meeting Learn more about our presentations here: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-details-oral-presentations-2025 https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-details-oral-presentations-2025"
X Link 2025-06-03T21:54Z [---] followers, [---] engagements
"Next week we will announce our second quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2025-financial"
X Link 2025-08-05T20:07Z [---] followers, [---] engagements
"Today we reported our second quarter [----] earnings and provided a corporate update. Read the release: #genetherapy #Rettsyndrome https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2025-financial"
X Link 2025-08-12T12:04Z [---] followers, [---] engagements
"Were pleased to announce our new supplemental data analysis from Part A of the REVEAL Phase 1/2 trials for TSHA-102 in #Rettsyndrome that further highlights the consistent multi-domain impact of TSHA-102 on activities of daily living. The analysis will be presented later today at the 54th Child Neurology Society Annual Meeting. Learn more: #CNSAM https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-presents-new-supplemental-data-analysis https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-presents-new-supplemental-data-analysis"
X Link 2025-10-09T12:04Z [---] followers, [---] engagements
"Next week we will announce our third quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-third-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-third-quarter-2025-financial"
X Link 2025-10-28T12:55Z [---] followers, [---] engagements
"Taysha is pleased to be a sponsor of the International Rett Syndrome Foundations Strollathon events to help fundraise advocate and accelerate research for #Rettsyndrome. Throughout the month of October members of the #TayshaTeam were honored to join the Rett syndrome community in Strolls around the country to support IRSFs mission. #RettSyndromeAwarenessMonth @Rettsyndrome https://twitter.com/i/web/status/1983896674922803525 https://twitter.com/i/web/status/1983896674922803525"
X Link 2025-10-30T14:00Z [---] followers, [---] engagements
"Taysha is proud to serve as a sponsor of @Rettsyndromes RettEd Days designed to provide educational resources and support to families affected by #Rettsyndrome. There are two more RettEd Days on the calendar in [----] and we hope to see you there Learn more: https://www.rettsyndrome.org/families/rett-education/retted-days/#retteddays-upcoming Registration is now open for our final RettEd Day of [----] with @BostonChildrens Join speakers including Professor Mriganka Sur from MIT clinic director Dr. David Liebermann and CPNP Grace Correa for a full day of programming. Learn more and register:"
X Link 2025-08-22T15:32Z [---] followers, [---] engagements
"Last week Sean Nolan Tayshas CEO and Board Chairman and Fred Porter our Chief of Staff and Technical Operations Officer joined industry leaders at the [----] @Official_Cantor Global Healthcare Conference to discuss company updates and highlight progress on our lead TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome. Learn more about our approach: https://tayshagtx.com/pipeline/ https://tayshagtx.com/pipeline/"
X Link 2025-09-12T13:15Z [---] followers, [---] engagements
"It's #RettSyndromeAwarenessMonth and were proud to help raise awareness and support the individuals and families impacted by #Rettsyndrome as we continue our mission to bring a #genetherapy to the Rett syndrome community"
X Link 2025-10-01T13:30Z [---] followers, [---] engagements
"Today we announced exciting regulatory updates on our TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome supporting the path toward potential registration: - The U.S. FDA granted Breakthrough Therapy designation to TSHA-102 - We reached final alignment with the FDA on all aspects of our REVEAL pivotal trial protocol and statistical analysis plan that are intended to support our planned Biologics License Application submission for TSHA-102 Read the release to learn more:"
X Link 2025-10-02T12:10Z [---] followers, [---] engagements
"Next week Sean Nolan our Chairman and CEO will serve as a panelist during the Special Plenary session taking place Monday October [--] at the @RareDiseases National Organization for Rare Disorders Rare Diseases and Orphan Products Breakthrough Summit. The panel will be comprised of #biotech leaders investors and entrepreneurs who will share their perspectives on the outlook for #raredisease investment in [----] and beyond. How are #biotech and #pharma leaders meeting the moment for #RareDisease patients Hear from CEOs and senior leaders at the [----] NORD Breakthrough Summit about newborn screening"
X Link 2025-10-14T15:25Z [---] followers, [---] engagements
"Today we reported our third quarter [----] earnings and provided a corporate update. Were pleased with the progress made across our lead TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome in support of our path to potential registration. Read the release to learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2025-financial"
X Link 2025-11-04T12:03Z [---] followers, [---] engagements
"Werecounting down toRare Disease DayRecognized on the last day of February each year#RareDiseaseDay is a global initiative to raise awareness and generate support for everyone on a rare medical journey. Learn more about @rarediseaseday and how to get involved by https://www.rarediseaseday.org/ https://www.rarediseaseday.org/"
X Link 2026-02-10T20:54Z [---] followers, [--] engagements
"Today we announced that the first patient was dosed in our REVEAL pivotal trial in Q4 [----] and that weve reached written alignment with the U.S. FDA on our ASPIRE safety-focused trial and the data for inclusion in our planned BLA submission to support a broad label for TSHA-102 for patients aged [--] years with #Rettsyndrome. Read the release to learn more about the progress across our TSHA-102 #genetherapy program in clinical evaluation for Rett syndrome: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-progress-across-tsha-102-pivotal"
X Link 2026-01-06T13:04Z [---] followers, [---] engagements
"Today we reported our third quarter [----] earnings and provided a corporate update. Were pleased with the progress made across our lead TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome in support of our path to potential registration. Read the release to learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-third-quarter-2025-financial"
X Link 2025-11-04T12:03Z [---] followers, [---] engagements
"Taysha is pleased to be a sponsor of the International Rett Syndrome Foundations Strollathon events to help fundraise advocate and accelerate research for #Rettsyndrome. Throughout the month of October members of the #TayshaTeam were honored to join the Rett syndrome community in Strolls around the country to support IRSFs mission. #RettSyndromeAwarenessMonth @Rettsyndrome https://twitter.com/i/web/status/1983896674922803525 https://twitter.com/i/web/status/1983896674922803525"
X Link 2025-10-30T14:00Z [---] followers, [---] engagements
"Next week we will announce our third quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-third-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-third-quarter-2025-financial"
X Link 2025-10-28T12:55Z [---] followers, [---] engagements
"In recognition of #RettSyndromeAwarenessMonth the Taysha team had the privilege of meeting Kelsey and her daughter Molly who lives with #Rettsyndrome. Kelsey shared her familys journey with Rett syndrome and offered her perspective on what meaningful progress toward a treatment would look like. We are grateful to Kelsey for sharing her story and for her unwavering dedication to raising awareness of Rett syndrome. We also joined the International Rett Syndrome Foundations 2nd annual #PurpleOut in support of families impacted by Rett syndrome @RettSyndrome"
X Link 2025-10-22T15:14Z [---] followers, [---] engagements
"Next week Sean Nolan our Chairman and CEO will serve as a panelist during the Special Plenary session taking place Monday October [--] at the @RareDiseases National Organization for Rare Disorders Rare Diseases and Orphan Products Breakthrough Summit. The panel will be comprised of #biotech leaders investors and entrepreneurs who will share their perspectives on the outlook for #raredisease investment in [----] and beyond. How are #biotech and #pharma leaders meeting the moment for #RareDisease patients Hear from CEOs and senior leaders at the [----] NORD Breakthrough Summit about newborn screening"
X Link 2025-10-14T15:25Z [---] followers, [---] engagements
"How are #biotech and #pharma leaders meeting the moment for #RareDisease patients Hear from CEOs and senior leaders at the [----] NORD Breakthrough Summit about newborn screening curative therapies and strategic collaboration. Register now: 🔑 @AcadiaPharma @MPSSociety @TayshaGTx @TheMightySite https://bit.ly/4lSAkDq https://bit.ly/4lSAkDq"
X Link 2025-09-16T19:09Z 39.8K followers, [---] engagements
"Were pleased to announce our new supplemental data analysis from Part A of the REVEAL Phase 1/2 trials for TSHA-102 in #Rettsyndrome that further highlights the consistent multi-domain impact of TSHA-102 on activities of daily living. The analysis will be presented later today at the 54th Child Neurology Society Annual Meeting. Learn more: #CNSAM https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-presents-new-supplemental-data-analysis https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-presents-new-supplemental-data-analysis"
X Link 2025-10-09T12:04Z [---] followers, [---] engagements
"Today we announced exciting regulatory updates on our TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome supporting the path toward potential registration: - The U.S. FDA granted Breakthrough Therapy designation to TSHA-102 - We reached final alignment with the FDA on all aspects of our REVEAL pivotal trial protocol and statistical analysis plan that are intended to support our planned Biologics License Application submission for TSHA-102 Read the release to learn more:"
X Link 2025-10-02T12:10Z [---] followers, [---] engagements
"It's #RettSyndromeAwarenessMonth and were proud to help raise awareness and support the individuals and families impacted by #Rettsyndrome as we continue our mission to bring a #genetherapy to the Rett syndrome community"
X Link 2025-10-01T13:30Z [---] followers, [---] engagements
"Last week Sean Nolan Tayshas CEO and Board Chairman and Fred Porter our Chief of Staff and Technical Operations Officer joined industry leaders at the [----] @Official_Cantor Global Healthcare Conference to discuss company updates and highlight progress on our lead TSHA-102 #genetherapy program in clinical evaluation for #Rettsyndrome. Learn more about our approach: https://tayshagtx.com/pipeline/ https://tayshagtx.com/pipeline/"
X Link 2025-09-12T13:15Z [---] followers, [---] engagements
"Taysha is proud to serve as a sponsor of @Rettsyndromes RettEd Days designed to provide educational resources and support to families affected by #Rettsyndrome. There are two more RettEd Days on the calendar in [----] and we hope to see you there Learn more: https://www.rettsyndrome.org/families/rett-education/retted-days/#retteddays-upcoming Registration is now open for our final RettEd Day of [----] with @BostonChildrens Join speakers including Professor Mriganka Sur from MIT clinic director Dr. David Liebermann and CPNP Grace Correa for a full day of programming. Learn more and register:"
X Link 2025-08-22T15:32Z [---] followers, [---] engagements
"Registration is now open for our final RettEd Day of [----] with @BostonChildrens Join speakers including Professor Mriganka Sur from MIT clinic director Dr. David Liebermann and CPNP Grace Correa for a full day of programming. Learn more and register: http://rettsyndrome.org/retted-bch25 http://rettsyndrome.org/retted-bch25"
X Link 2025-07-29T14:00Z [----] followers, [---] engagements
"Today we reported our second quarter [----] earnings and provided a corporate update. Read the release: #genetherapy #Rettsyndrome https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-second-quarter-2025-financial"
X Link 2025-08-12T12:04Z [---] followers, [---] engagements
"Next week we will announce our second quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-second-quarter-2025-financial"
X Link 2025-08-05T20:07Z [---] followers, [---] engagements
"Were thrilled to announce details for our upcoming oral presentations at the @rettsyndrome [----] International Rett Syndrome Foundation (RSF) Rett Syndrome Scientific Meeting Learn more about our presentations here: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-details-oral-presentations-2025 https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-details-oral-presentations-2025"
X Link 2025-06-03T21:54Z [---] followers, [---] engagements
"Were pleased to share key elements of our pivotal Part B trial design for TSHA-102 in #Rettsyndrome enabled by @Rettsyndromes natural history dataset and positive clinical data from Part A of our REVEAL Phase 1/2 trials evaluating TSHA-102. Learn more: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-pivotal-part-b-trial-design https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-announces-pivotal-part-b-trial-design"
X Link 2025-05-28T20:02Z [---] followers, [----] engagements
"Today we reported our first quarter [----] earnings and provided a corporate update. Read the release: #genetherapy #Rettsyndrome https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-reports-first-quarter-2025-financial"
X Link 2025-05-15T12:07Z [---] followers, [---] engagements
"Next week we will announce our first quarter [----] earnings and provide a corporate update. For more information visit: https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2025-financial https://ir.tayshagtx.com/news-releases/news-release-details/taysha-gene-therapies-release-first-quarter-2025-financial"
X Link 2025-05-08T20:07Z [---] followers, [---] engagements
"Congrats to Laura Sepp-Lorenzino PhD and Steven Gray PhD on their election to @ASGCTherapy's Board of Directors Were thrilled to see them share their expertise to help advance genetic and cellular therapies. https://www.asgct.org/publications/news/april-2025/new-board-members-2025 https://www.asgct.org/publications/news/april-2025/new-board-members-2025"
X Link 2025-04-29T18:29Z [---] followers, [---] engagements
"We're a proud sponsor of @Rettsyndrome's new learning experience where families can learn more about #RettSyndrome research clinical trials and the future of #genetherapy. Congratulations to #IRSF on the launch of this exciting and educational program "Rett Forward: A Clinical Trial Master Class" will break down everything you need to know about Rett research & clinical trials. You're already Rett Research Ready; now let's move Rett Forward Module [--] drops later this month Brought to you thanks to @NeurogeneInc & @TayshaGTx. https://t.co/GqqAGkdrcI "Rett Forward: A Clinical Trial Master Class""
X Link 2025-04-24T14:27Z [---] followers, [---] engagements
""Rett Forward: A Clinical Trial Master Class" will break down everything you need to know about Rett research & clinical trials. You're already Rett Research Ready; now let's move Rett Forward Module [--] drops later this month Brought to you thanks to @NeurogeneInc & @TayshaGTx"
X Link 2025-04-22T14:00Z [----] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/creator/twitter::TayshaGTx